Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 10, 2011, Pages 4631-4638

  Neuman, Benjamin W ^a   Bederka, Lydia H ^b   Stein, David A ^c   Ting, Joey P C ^d   Moulton, Hong M ^e   Buchmeier, Michael J ^b  

^a UNIVERSITY OF READING   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d ELI LILLY AND COMPANY   (United States)

^e OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GENOMIC RNA; MORPHOLINE DERIVATIVE; OLIGOMER; PEPTIDE CONJUGATED PHOSPHORODIAMIDATE MORPHOLINO OLIGOMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARENAVIRUS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG CONJUGATION; IN VIVO STUDY; JUNIN VIRUS; LIVER; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PICHINDE ARENAVIRUS; PRIORITY JOURNAL; RNA INTERFERENCE; RNA SEQUENCE; RNA SYNTHESIS; RNA TRANSLATION; VIRUS GENOME; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; ARENAVIRIDAE INFECTIONS; ARENAVIRUS; ARENAVIRUSES, NEW WORLD; CELL LINE; CERCOPITHECUS AETHIOPS; GENOME, VIRAL; JUNIN VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICROBIAL SENSITIVITY TESTS; MORPHOLINOS; PEPTIDES; PICHINDE VIRUS; PROTEIN BIOSYNTHESIS; RNA, VIRAL; VERO CELLS; VIRUS REPLICATION;

EID: 80052855889     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00650-11     Document Type: Article

References (35)

1. Abes, S., et al. 2006. Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents. J. Control Release. 116:304-313. (Pubitemid 44827406)
2. Anantpadma, M., D. A. Stein, and S. Vrati. 2010. Inhibition of Japanese encephalitis virus replication in cultured cells and mice by a peptide-conjugated morpholino oligomer. J. Antimicrob. Chemother. 65:953-961.
3. Artuso, M. C., P. C. Ellenberg, L. A. Scolaro, E. B. Damonte, and C. C. Garcia. 2009. Inhibition of Junin virus replication by small interfering RNAs. Antiviral Res. 84:31-37.
4. Auperin, D. D., R. W. Compans, and D. H. Bishop. 1982. Nucleotide sequence conservation at the 3′ termini of the virion RNA species of New World and Old World arenaviruses. Virology 121:200-203.
5. Buchmeier, M. J., J. C. de la Torre, and C. J. Peters. 2007. Arenaviridae: The Viruses and Their Replication, p. 1791-1828. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
6. Buchmeier, M. J., J. H. Elder, and M. B. Oldstone. 1978. Protein structure of lymphocytic choriomeningitis virus: identification of the virus structural and cell associated polypeptides. Virology 89:133-145.
7. Buchmeier, M. J., H. A. Lewicki, O. Tomori, and M. B. Oldstone. 1981. Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses. Virology 113:73-85.
8. Burrer, R., et al. 2007. Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models. J. Virol. 81:5637-5648. (Pubitemid 46847003)
9. Deas, T. S., et al. 2007. In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus. Antimicrob. Agents Chemother. 51:2470-2482.
10. Deas, T. S., et al. 2005. Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication. J. Virol. 79:4599-4609. (Pubitemid 40464211)
11. Garcin, D., and D. Kolakofsky. 1990. A novel mechanism for the initiation of Tacaribe arenavirus genome replication. J. Virol. 64:6196-6203.
12. Garcin, D., and D. Kolakofsky. 1992. Tacaribe arenavirus RNA synthesis in vitro is primer dependent and suggests an unusual model for the initiation of genome replication. J. Virol. 66:1370-1376.
13. Jahrling, P. B., C. J. Peters, and E. L. Stephen. 1984. Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys. J. Infect. Dis. 149:420-427.
14. Li, X. D., H. Lankinen, N. Putkuri, O. Vapalahti, and A. Vaheri. 2005. Tula hantavirus triggers pro-apoptotic signals of ER stress in Vero E6 cells. Virology 333:180-189. (Pubitemid 40222201)
15. Maiztegui, J. I., et al. 1998. Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group. J. Infect. Dis. 177:277-283.
16. McCormick, J. B. 1986. Clinical, epidemiologic, and therapeutic aspects of Lassa fever. Med. Microbiol. Immunol. 175:153-155.
17. Meyer, B. J., and P. J. Southern. 1993. Concurrent sequence analysis of 5′ and 3′ RNA termini by intramolecular circularization reveals 5′ nontemplated bases and 3′ terminal heterogeneity for lymphocytic choriomeningitis virus mRNAs. J. Virol. 67:2621-2627.
18. Moulton, H. M., M. H. Nelson, S. A. Hatlevig, M. T. Reddy, and P. L. Iversen. 2004. Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides. Bioconjug Chem. 15:290-299.
19. Neuman, B. W., et al. 2005. Complementarity in the supramolecular design of arenaviruses and retroviruses revealed by electron cryomicroscopy and image analysis. J. Virol. 79:3822-3830. (Pubitemid 40327969)
20. Neuman, B. W., et al. 2005. Inhibition, escape, and attenuated growth of severe acute respiratory syndrome coronavirus treated with antisense morpholino oligomers. J. Virol. 79:9665-9676. (Pubitemid 41022309)
21. Ogbu, O., E. Ajuluchukwu, and C. J. Uneke. 2007. Lassa fever in West African sub-region: an overview. J. Vector Borne Dis. 44:1-11.
22. Paessler, S., et al. 2008. Inhibition of alphavirus infection in cell culture and in mice with antisense morpholino oligomers. Virology 376:357-370.
23. Perez, M., and J. C. de la Torre. 2003. Characterization of the genomic promoter of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 77:1184-1194. (Pubitemid 36055541)
24. Pinschewer, D. D., M. Perez, and J. C. de la Torre. 2005. Dual role of the lymphocytic choriomeningitis virus intergenic region in transcription termination and virus propagation. J. Virol. 79:4519-4526. (Pubitemid 40388390)
25. Polyak, S. J., S. Zheng, and D. G. Harnish. 1995. 5′ termini of Pichinde arenavirus S RNAs and mRNAs contain nontemplated nucleotides. J. Virol. 69:3211-3215.
26. Raju, R., et al. 1990. Nontemplated bases at the 5′ ends of Tacaribe virus mRNAs. Virology 174:53-59. (Pubitemid 20030950)
27. Sánchez, A. B., M. Perez, T. Cornu, and J. C. de la Torre. 2005. RNA interference-mediated virus clearance from cells both acutely and chronically infected with the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 79:11071-11081. (Pubitemid 41170648)
28. Schmittgen, T. D., and K. J. Livak. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3:1101-1108.
29. Sleeman, K., et al. 2009. Inhibition of measles virus infections in cell cultures by peptide-conjugated morpholino oligomers. Virus Res. 140:49-56.
30. Stein, D., E. Foster, S. B. Huang, D. Weller, and J. Summerton. 1997. A specificity comparison of four antisense types: morpholino, 2′-O-methyl RNA, DNA, and phosphorothioate DNA. Antisense Nucleic Acid Drug Dev. 7:151-157. (Pubitemid 27323073)
31. Stein, D. A. 2008. Inhibition of RNA virus infections with peptide-conjugated morpholino oligomers. Curr. Pharm. Des. 14:2619-2634.
32. Stein, D. A., et al. 2008. Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus. J. Antimicrob. Chemother. 62:555-565.
33. Stone, J. K., et al. 2008. A morpholino oligomer targeting highly conserved internal ribosome entry site sequence is able to inhibit multiple species of picornavirus. Antimicrob. Agents Chemother. 52:1970-1981. 508.
34. Summerton, J. 1999. Morpholino antisense oligomers: the case for an RNase H-independent structural type. Biochim. Biophys. Acta 1489:141-158.
35. Summerton, J., and D. Weller. 1997. Morpholino antisense oligomers: design, preparation, and properties. Antisense Nucleic Acid Drug Dev. 7:187-195. (Pubitemid 27323077)